STONY BROOK, NY / ACCESS Newswire / May 29, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (“Applied DNA” or the “Company”), ...

Replacing PEG with PCB in lipid nanoparticles led to potent mRNA vaccines that avoided unwanted immune responses.

A new material developed at Cornell University could significantly improve the delivery and effectiveness of mRNA vaccines by ...

Life on Earth possesses an exceptional ability to self-reproduce, which, even on a simple cellular level, is driven by ...

The personalized CRISPR treatment could be the future of gene therapy, but hurdles remain before everyone has access.

Chemists at UCL and the MRC Laboratory of Molecular Biology have demonstrated how RNA (ribonucleic acid) might have ...

Telesis Bio Inc. (OTCMKTS: TBIO), a leading provider of DNA and mRNA synthesis solutions to accelerate therapeutic discovery with fast and flexible on-site automated foundries, today announced a new ...

Strand Therapeutics, a leader in next-generation mRNA-based therapeutics, today announced exciting preliminary Phase 1 ...

Ankyra Therapeutics is a biotech developing anchored immunotherapies aimed at enhancing the therapeutic window of ...

4basebio made notable strides in product supply for clinical trials, providing opDNA™ to HelixNano Technologies Inc. for an mRNA vaccine trial and supplying high-quality and GMP-grade synthetic DNA to ...

The Board of 4basebio plc is pleased to report the results for the financial year ended 31 December 2024. The annual report and accounts together with a notice of the Company’s annual general meeting, ...

(24) Previously, this technology has not been used to profile EV mRNA because of the low abundance of mRNAs in EVs. In this study, we established a new protocol that allows robust, sensitive, and ...